Explore how computational drug design is creating precise inhibitors for HCPTP, a protein that drives cancer metastasis, using virtual screening and rational design approaches.
Discover how CX-8184, a potent inhibitor of protein kinase CK2, blocks cancer metastasis by disrupting epithelial-to-mesenchymal transition in cancer cells.